Pharmaceuticals
Company Overview of Oxford GlycoSciences Plc
Company Overview
As of July 17, 2003, Oxford GlycoSciences Plc was acquired by Celltech Group plc. Oxford GlycoSciences Plc operates as a biopharmaceutical company applying proteomics technologies and glycobiology to the discovery, development, and commercialisation of novel therapeutic products. Its drug discovery efforts focus on three main therapeutic areas: cancer, anti-infective, and glycolipid storage disorders. The company is headquartered at Abingdon, United Kingdom with an additional office in Oxfordshire, United Kingdom.
The Forum
86 Milton Park
Abingdon, OX14 4RY
United Kingdom
Fax:
44 12 3520 8020
Key Executives for Oxford GlycoSciences Plc
Oxford GlycoSciences Plc does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Boehringer Ingelheim Limited | Europe |
| GT Biologics Limited | Europe |
| PharmEcosse Limited | Europe |
| pSiMedica Limited | Europe |
| Shire Pharmaceuticals, Ltd. | Europe |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Washington, DC | Inventiv HealthPosted: May 22
- Bridgewater, NJ | AptalisPosted: May 22
- Field, KY | Forest LaboratoriesPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact Oxford GlycoSciences Plc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
